These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15159442)

  • 1. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
    Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.
    Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
    Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats.
    Chiarugi A
    Br J Pharmacol; 2002 Nov; 137(6):761-70. PubMed ID: 12411406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.
    Haddad M; Rhinn H; Bloquel C; Coqueran B; Szabó C; Plotkine M; Scherman D; Margaill I
    Br J Pharmacol; 2006 Sep; 149(1):23-30. PubMed ID: 16865091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.
    Yam-Canul P; Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
    Basic Clin Pharmacol Toxicol; 2008 May; 102(5):483-8. PubMed ID: 18331393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion.
    Stone DH; Albadawi H; Conrad MF; Entabi F; Stoner MC; Casey PJ; Cambria RP; Watkins MT
    Am J Surg; 2009 Aug; 198(2):250-5. PubMed ID: 19268911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
    Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
    Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-alpha production triggered by the loss of blood-brain barrier integrity.
    Scott GS; Kean RB; Fabis MJ; Mikheeva T; Brimer CM; Phares TW; Spitsin SV; Hooper DC
    J Neuroimmunol; 2004 Oct; 155(1-2):32-42. PubMed ID: 15342194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
    J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms.
    Dutra RC; de Souza PR; Bento AF; Marcon R; Bicca MA; Pianowski LF; Calixto JB
    Biochem Pharmacol; 2012 Feb; 83(4):531-42. PubMed ID: 22155310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia.
    Toller IM; Altmeyer M; Kohler E; Hottiger MO; Müller A
    Cancer Res; 2010 Jul; 70(14):5912-22. PubMed ID: 20634404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein.
    Mazzon E; Genovese T; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Meli R; Sessa E; Cuzzocrea S
    Eur J Pharmacol; 2006 Nov; 549(1-3):149-56. PubMed ID: 16979620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PJ34 on spinal cord tissue viability and gene expression in a murine model of thoracic aortic reperfusion injury.
    Stone DH; Conrad MF; Albadawi H; Entabi F; Stoner MC; Cambria RP; Watkins MT
    Vasc Endovascular Surg; 2009; 43(5):444-51. PubMed ID: 19640911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
    Prasad R; Giri S; Nath N; Singh I; Singh AK
    J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
    Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
    J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.